(Press-News.org) Scientists believe they may have found a new target for treating triple negative breast cancer – one of the more difficult breast cancers to treat successfully and for which there is no targeted therapy at present.
Triple negative breast cancer (TNBC) is a cancer that does not express receptors for oestrogen (ER), progesterone (PR) or the human epidermal growth factor (HER2). It tends to be more aggressive, occurs more often in younger women, and is difficult to treat successfully as it lacks the receptors that currently available targeted therapies such as tamoxifen and trastuzumab (Herceptin) can home in on. Surgery, followed by chemotherapy, is the usual treatment.
Now researchers in Dublin (Ireland) have found that TNBC cells respond to compounds that disrupt the signalling processes of another receptor, EGFR (epidermal growth factor receptor), high levels of which are expressed in TNBC. In a presentation to the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin today (Wednesday), Dr Patricia McGowan, a senior postdoctoral scientist at University College Dublin, said the compounds had reduced the growth of TNBC cells in the laboratory by up to 91%.
"As these cancers possess high levels of EGFR, we thought that they may be dependent on EGFR signalling," she said. "ADAMs (a disintegrin and metalloprotease) are enzymes that are involved in the activation of EGFR binding-proteins (i.e. ligands) during the signalling process, and so we thought that inhibiting them might be a potential therapeutic option for TNBC, either alone or in combination with drugs that target EGFR, such as gefitinib."
Dr McGowan and her colleagues tested gefitinib and a compound that specifically inhibits ADAM17 on breast cancer cell lines. The compound, known as TMI-002 (Pfizer), was similar to gefitinib in its ability to inhibit the growth of cancer cells. Gefitinib is not used in breast cancer treatment at present, but the researchers tested it to see whether inhibiting ADAM and EGFR simultaneously would work synergistically. "We did not observe any additional benefit when we combined the ADAM inhibitor with gefitinib; however, adding gefitinib 72 hours after ADAM inhibitor treatment was more effective than adding both inhibitors simultaneously, although this did not reach statistical significance."
In addition, another, as yet un-named compound that blocks both ADAM10 and ADAM17 resulted in significant effect on a range of TNBC cell lines. "We found that it reduced the growth of these cells by up to 91%," she said. "We have also found that treatment of TNBC cells with this compound reduced their ability to migrate, a process that is vital for the progression of cancer.
"Triple negative breast cancers comprise 10-20% of all breast cancer cases. Women with TNBC tend to present with higher grade, larger tumours, are younger at diagnosis, have a higher incidence of metastases and have a shorter time to recurrence compared to other breast cancer types. One reason for the poor prognosis for this group is the lack of targeted therapies for these women. Having found that an ADAM inhibitor can reduce the proliferation of TNBC cell lines, we hope that ADAMs may be a useful therapeutic target."
The scientists hope that inhibiting ADAMs might also be a possible treatment for other cancers in which members of the EGFR 'family' are active. In addition to EGFR, the 'family' consists of HER2, HER3 and HER4, and these are implicated in a number of cancers such as lung, colorectal, head and neck, and pancreatic cancers.
"Theoretically, inhibiting ADAMs should block downstream signalling from all four EGFR family members and thus potentially reduce cancer progression. We are excited that we have seen an effect in this particularly aggressive subgroup of breast cancers but propose that we will see an effect in other cancer settings also," said Dr McGowan.
"We hope to expand our investigation of these compounds using a larger panel of cell lines, moving into animal models, and eventually into clinical trials."
###
Abstract no: 129. Poster on Wednesday 17 November in the Exhibition Hall (ground level) from 08.00/09.00 hrs to 18.00 hrs CET.
Notes:
[1] EORTC [European Organisation for Research and Treatment of Cancer, NCI [National Cancer Institute], AACR [American Association for Cancer Research].
[2] This work was funded by Science Foundation Ireland, Strategic Research Cluster Award (08/SRC/B1410) to Molecular Therapeutics for Cancer Ireland.
END
Washington, D.C. (November 16, 2010) -- For more than 250 years, researchers have known that under certain conditions vapor bubbles can form in fluids moving swiftly over a surface. These bubbles soon collapse with such great force that they can poke holes in steel and damage objects such as ship propellers, turbine blades, nozzles and pump impellers.
Scientists have conducted extensive research for decades to try to understand this phenomenon -- called cavitation. But most experiments to date have been related to open-water objects like ship propellers.
Now a group ...
Washington, D.C. (November 16, 2010) -- While our direct knowledge of black holes in the universe is limited to what we can observe from thousands or millions of light years away, a team of Chinese physicists has proposed a simple way to design an artificial electromagnetic (EM) black hole in the laboratory.
In the Journal of Applied Physics, Huanyang Chen at Soochow University and colleagues have presented a design of an artificial EM black hole designed using five types of composite isotropic materials, layered so that their transverse magnetic modes capture EM waves ...
Washington, D.C. (November 16, 2010) -- In a move that holds great significance for the semiconductor industry, a team of researchers has created an alternative to conventional logic gates, demonstrated them in silicon, and dubbed them "chaogates." The researchers present their findings in Chaos, a journal published by the American Institute of Physics.
Simply put, they used chaotic patterns to encode and manipulate inputs to produce a desired output. They selected desired patterns from the infinite variety offered by a chaotic system. A subset of these patterns was ...
CINCINNATI—Researchers at the University of Cincinnati (UC) have found that fat around the outside of arteries may lead to the development of cardiovascular disease and could be linked to its onset in individuals with diabetes.
David Manka, PhD, a researcher in the division of cardiovascular diseases, and his team found that this fat—known as perivascular adipose tissue—could possibly lead to the formation of fatty buildup inside of arteries and could cause existing buildup to break loose, leading to stroke or heart attack.
These findings are being presented at the ...
The increase in the legal age of sexual consent from 14 to 16 years in 2008 may not be protecting those at greatest risk, according to researchers who have analyzed British Columbia population-based data and recommend additional strategies to safeguard vulnerable children and teens.
In the first study of its kind in Canada, researchers from the University of British Columbia and Simon Fraser University tested the government's reasons for changing the law. Their findings are published in the current issue the Canadian Journal of Human Sexuality.
According to the study's ...
Risø Energy Report 9 lists a wide range of energy technologies in the market with low or no emissions of greenhouse gases, describing how several of these will be made commercially available in the next decades.
However, it is not possible to make the world's energy supply CO2-free as cheaply as possible, using only technology development in the current energy systems. There must be room for technological leaps and there is a need for an integrated process to optimise the entire energy system, from energy production, through transformation into energy carriers, to energy ...
Long-nosed Cape rock elephant-shrews are fond of sticky treats, according to Dr. Petra Wester from the University of Stellenbosch in South Africa. Her investigations show for the first time that the elephant-shrew, Elephantulus edwardii, licks the nectar of the flowers and pollinates the Pagoda lily. Her results are published in Springer's journal, Naturwissenschaften – The Science of Nature.
Dr. Wester studied the behavior of the animals in the northern Cederberg area of South Africa, where Pagoda lily plants, Whiteheadia bifolia (Hyacinthaceae), are found in shady rock ...
CINCINNATI—University of Cincinnati (UC) researchers have discovered a new protein that could be cardioprotective during heart attack, potentially leading to more targeted treatments for patients at risk.
These findings are being presented at the American Heart Association's (AHA) Scientific Sessions in Chicago Nov. 16.
Researchers in the department of pharmacology and cell biophysics, led by Chi Keung Lam, a PhD student, and Wen Zhao, PhD, under the direction of Litsa Kranias, PhD, AHA distinguished scientist and chair of the department, found that HAX-1, an anti-cell ...
For Immediate Release – November 16, 2010 – (Toronto) – A new study from the Centre for Addiction and Mental Health (CAMH) has found that 29,000 Ontario students from grades 7-12 report behaviours indicating that they are gambling problematically. The study also found that more than two-thirds of these students reported problems with substance use and/or alcohol use, and 25% reported a suicide attempt in the past year.
The Ontario Youth Gambling Report looked at self-report data from over 9,000 students across Ontario to monitor trends and areas for concern regarding ...
Dr. Joseph Glavy at Stevens Institute of Technology studies the smallest and most basic elements of life. The Assistant Professor of Chemical Biology runs the Glavy Lab, where advanced student scientists study the nuclear pore complexes (NPCs) in cells, observing the minutest mechanisms of life as they unfold during mitosis. The Glavy Lab's formal purpose is to study the NPC at the molecular level in the pursuit of the unknown or unexpected in the well-studied but not always well-understood nuclei of living cells.
His team has uncovered a disease-related protein outside ...
